We are live on
!
Find out more
TD Asset Management Portfolio holdings
AUM
$115B
1-Year Est. Return
41.58%
This Fund
S&P 500
This Quarter
Est. Return
+19.89%
1 Year Est. Return
+41.58%
3 Year Est. Return
+119.77%
5 Year Est. Return
+143.7%
10 Year Est. Return
+448.77%
AUM
$115B
AUM Growth
-$7.82B
(-6.3%)
Cap. Flow
-$21.7B
Cap. Flow
% of AUM
-18.8%
Top 10 Holdings %
Top 10 Hldgs %
26.54%
Holding
1,342
New
112
Increased
345
Reduced
707
Closed
126
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$219M |
| 2 |
CSX Corp
CSX
|
+$137M |
| 3 |
Seagate
STX
|
+$127M |
| 4 |
Micron Technology
MU
|
+$101M |
| 5 |
Interactive Brokers
IBKR
|
+$98.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royal Bank of Canada
RY
|
+$1.38B |
| 2 |
Toronto Dominion Bank
TD
|
+$1.33B |
| 3 |
Apple
AAPL
|
+$945M |
| 4 |
Microsoft
MSFT
|
+$812M |
| 5 |
NVIDIA
NVDA
|
+$766M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.55% |
| 2 | Financials | 22.29% |
| 3 | Industrials | 10.09% |
| 4 | Healthcare | 8.22% |
| 5 | Energy | 7.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Corvus Pharmaceuticals
CRVS
$1.1B
| $1.23M | ﹤0.01% |
82,596
-41,142
| -33% | -$571K |
|
|
WHK
1052
WhiteHawk Minerals Corp
WHK
$675M
| $1.23M | ﹤0.01% |
+44,304
| New | +$1.2M |
|
1053
GlobalFoundries
GFS
$23.9B
| $1.22M | ﹤0.01% |
14,835
+880
| +6% | +$61.5K |
|
1054
Cabaletta Bio
CABA
$493M
| $1.22M | ﹤0.01% |
391,472
+324,548
| +485% | +$1.07M |
|
|
COAG
1055
Hemab Therapeutics
COAG
$1.89B
| $1.22M | ﹤0.01% |
+33,098
| New | +$913K |
|
1056
Kratos Defense & Security Solutions
KTOS
$8.93B
| $1.2M | ﹤0.01% |
24,028
-18,718
| -44% | -$1.13M |
|
1057
Hagerty
HGTY
$1.55B
| $1.19M | ﹤0.01% |
100,184
| – | – |
|
1058
Horace Mann Educators
HMN
$2.02B
| $1.18M | ﹤0.01% |
22,800
| – | – |
|
1059
Flowers Foods
FLO
$1.27B
| $1.17M | ﹤0.01% |
148,500
| – | – |
|
|
SLSR
1060
Solaris Resources
SLSR
$1.22B
| $1.17M | ﹤0.01% |
139,195
+6,940
| +5% | +$67.2K |
|
1061
Camtek
CAMT
$6.25B
| $1.17M | ﹤0.01% |
7,403
+552
| +8% | +$97.9K |
|
1062
SharkNinja
SN
$23.9B
| $1.16M | ﹤0.01% |
+7,616
| New | +$912K |
|
1063
Alto Neuroscience
ANRO
$1.24B
| $1.16M | ﹤0.01% |
43,800
| – | – |
|
1064
Telesat
TSAT
$747M
| $1.15M | ﹤0.01% |
+22,722
| New | +$1.1M |
|
1065
Wave Life Sciences
WVE
$902M
| $1.13M | ﹤0.01% |
194,026
-144,800
| -43% | -$960K |
|
1066
Vishay Precision Group
VPG
$806M
| $1.12M | ﹤0.01% |
7,488
| – | – |
|
1067
DaVita
DVA
$12.1B
| $1.12M | ﹤0.01% |
5,028
-798
| -14% | -$145K |
|
1068
A.O. Smith
AOS
$7.8B
| $1.12M | ﹤0.01% |
17,780
-1,824
| -9% | -$111K |
|
1069
Cellebrite
CLBT
$2.93B
| $1.11M | ﹤0.01% |
76,190
-66,078
| -46% | -$873K |
|
|
MH
1070
McGraw Hill
MH
$2.53B
| $1.1M | ﹤0.01% |
116,548
-308,334
| -73% | -$3.72M |
|
1071
Pricesmart
PSMT
$5.21B
| $1.1M | ﹤0.01% |
5,634
+212
| +4% | +$35.3K |
|
1072
Travere Therapeutics
TVTX
$6.2B
| $1.1M | ﹤0.01% |
19,330
+1,796
| +10% | +$79.6K |
|
1073
USCB Financial Holdings
USCB
$427M
| $1.09M | ﹤0.01% |
53,218
+8,522
| +19% | +$162K |
|
1074
Boot Barn
BOOT
$4.33B
| $1.09M | ﹤0.01% |
6,606
-396
| -6% | -$64.2K |
|
|
GRDN
1075
Guardian Pharmacy Services
GRDN
$2.94B
| $1.08M | ﹤0.01% |
25,864
| – | – |
|
Similar funds
TD Asset Management's Q2 2026 Portfolio in Review
As of Q2 2026, TD Asset Management held 1,342 positions worth $115B, down 6.3% from $123B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
TD Asset Management withdrew a net $21.7B in Q2 2026, closing 126 positions and reducing 707 holdings. Its most notable exit was Vanguard FTSE Developed Markets ETF, an estimated $88.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.
Against the trend, TD Asset Management opened a new position in SpaceX worth $80.5M.
- TD Asset Management's largest Q2 2026 buy was SpaceX: 470,977 shares worth $80.5M.
- TD Asset Management added most to Bank of New York Mellon in Q2 2026, an estimated $219M increase.
- TD Asset Management's biggest Q2 2026 reduction was Royal Bank of Canada, cutting an estimated $1.38B.
- TD Asset Management fully exited Vanguard FTSE Developed Markets ETF in Q2 2026, selling an estimated $88.5M.
- TD Asset Management's ten largest holdings make up 27% of its $115B portfolio in Q2 2026.
- TD Asset Management opened 112 new positions and closed 126 in Q2 2026.
- TD Asset Management's portfolio value fell 6.3% quarter-over-quarter to $115B.
Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.